Full coverage· Health· Updated
Health Ministry Orders Recall of Potentially Dangerous Drug IMAAVY
Israel's Ministry of Health has ordered the recall of the drug IMAAVY due to potential glass particle contamination in specific batches. The drug, distributed by Johnson & Johnson, is used to treat myasthenia gravis, and the recall is not expected to cause a shortage.
2 newsrooms · 1 language · since
Plus
What happened
- 01Health Ministry orders recall of IMAAVY drug due to glass particle risk.
- 02Johnson & Johnson is the distributor of the affected drug in Israel.
- 03IMAAVY treats generalized myasthenia gravis in adults and adolescents.
- 04Medical facilities must stop using, isolate, and return recalled batches.
- 05Recall is not expected to lead to a drug shortage in Israel.
The coverage
2 newsrooms on this story
Who covered it
- LeftNone
- CentreNone
- RightNone
- HarediNone
- ArabNone
- Other2
How it broke
See which of the 2 newsrooms broke it, and who waited